IV NEWS
Scientific publications - June 12, 2022
The European recommendations on the proper indication and use of peripheral venous access devices (ERPIUP) consensus was a project led…
News and innovation May 22, 2022
Achieving infection prevention and control – The Portuguese Experience
Creating a culture of awareness and action – Dr. Cristina Nunes, MD, FICE Bragança Hospital, Portugal. Healthcare-associated infections (HAIs) are…
“Complications of IV catheter therapy are simply the result of one complex and highly variable mechanical system—IV catheter equipment design,...
News and innovation May 8, 2022
IV original equipment manufacturer BD aids MedTech partners
BD as an original equipment manufacturer (OEM) offers guidance to MedTech partners on producing intravenous (IV) devices for drug preparation…
News and innovation April 23, 2022
World Immunisation Week—vaccines and syringes then and now
World Immunisation Week is 24–30 April. We didn’t always have access to safe and effective vaccines administered with disposable syringes.…
News and innovation April 17, 2022
The European Union Medical Device Regulation (MDR) 2017/745
The European Union (EU) adopted the MDR almost 10 years after it launched a formal review of the European Regulatory…
News and innovation March 20, 2022
Using an aseptic technique is not only the most commonly performed procedure to prevent infection in healthcare, but it is…
News and innovation March 6, 2022
A BD webinar—Is your syringe intravenous (IV) infusion system safe for your patients?
BD recently welcomed Professor Markus Weiss, MD to speak about advancing patient safety in syringe intravenous (IV) infusion systems. Syringe…
Fast fact
TIVA anaesthesia
Propofol-based total intravenous anaesthesia (TIVA) emits four orders of magnitude less greenhouse gases than inhaled anaesthesia with desflurane and N2O.